Related Experiment Video
Updated: Mar 1, 2026

05:28
A Mouse Model of Lumbar Spine Instability
Published on: April 23, 2021
9.2K
Animal models for disc degeneration-an update.
Li Jin1, Gary Balian1, Xudong Joshua Li2
1Department of Orthopaedic Surgery, University of Virginia, Charlottesville, VA, USA.
Histology and Histopathology
|June 6, 2017
Summary
Intervertebral disc degeneration causes significant back pain and economic burden. This review examines animal models used to study disc degeneration and highlights challenges in developing effective therapies.
Area of Science:
- Biomedical research
- Orthopedics
- Regenerative medicine
Background:
- Intervertebral disc degeneration is a primary cause of back pain, impacting individual health and the global economy.
- Despite advances, the underlying mechanisms of disc degeneration remain incompletely understood.
- Pre-clinical research has significantly improved comprehension, yet challenges persist.
Purpose of the Study:
- To review and analyze current animal models for studying intervertebral disc degeneration.
- To identify and discuss the limitations and difficulties associated with these animal models.
- To provide insights for future research directions in understanding and treating disc degeneration.
Main Methods:
- Literature review of pre-clinical studies utilizing animal models for intervertebral disc degeneration.
- Analysis of methodologies employed in various animal models.
- Identification of common challenges and limitations across different models.
Main Results:
- Various animal models exist, each with specific advantages and disadvantages for studying disc degeneration.
- Challenges include species-specific differences, model reproducibility, and translation to human conditions.
- Understanding cellular and molecular pathways is crucial for model development.
Conclusions:
- Animal models are essential for investigating intervertebral disc degeneration.
- Addressing model limitations is critical for advancing therapeutic strategies.
- Further research into cellular and molecular events will guide targeted treatments for back pain.

